PL363576A1 - Zastosowanie (R)-ibuprofeno-metanosulfonamidu i jego soli do leczenia i zapobiegania reakcjom odrzucania przeszczepionych organów - Google Patents

Zastosowanie (R)-ibuprofeno-metanosulfonamidu i jego soli do leczenia i zapobiegania reakcjom odrzucania przeszczepionych organów

Info

Publication number: PL363576A1
Authority: PL; Poland
Prior art keywords: prevention; treatment; rejection reactions; salts; transplanted organs
Prior art date: 2001-02-02

Application number

PL02363576A

Other languages

English (en)

Other versions

PL215109B1 (pl

Inventor

Riccardo Bertini

Francesco Colotta

Roberto Novellini

Original Assignee

Dompe S.P.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-02

Filing date

2002-01-30

Publication date

2004-11-29

2002-01-30 Application filed by Dompe S.P.A. filed Critical Dompe S.P.A.

2004-11-29 Publication of PL363576A1 publication Critical patent/PL363576A1/pl

2013-10-31 Publication of PL215109B1 publication Critical patent/PL215109B1/pl

Links

238000006243 chemical reaction Methods 0.000 title abstract 3
URZONQSEPBBTSB-HNCPQSOCSA-N methanesulfonamide;(2r)-2-[4-(2-methylpropyl)phenyl]propanoic acid Chemical compound CS(N)(=O)=O.CC(C)CC1=CC=C([C@@H](C)C(O)=O)C=C1 URZONQSEPBBTSB-HNCPQSOCSA-N 0.000 title abstract 3
230000002265 prevention Effects 0.000 title abstract 3
210000000056 organ Anatomy 0.000 title abstract 2
150000003839 salts Chemical class 0.000 title abstract 2
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical class NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 1
208000027418 Wounds and injury Diseases 0.000 abstract 1
230000006378 damage Effects 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
208000014674 injury Diseases 0.000 abstract 1
210000003734 kidney Anatomy 0.000 abstract 1
231100000252 nontoxic Toxicity 0.000 abstract 1
230000003000 nontoxic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Transplantation (AREA)
Vascular Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicinal Preparation (AREA)

PL363576A 2001-02-02 2002-01-30 Zastosowanie (R)-ibuprofeno-metanosulfonamidu i jego nietoksycznych soli do wytwarzania leków PL215109B1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT2001MI000206A ITMI20010206A1 (it)	2001-02-02	2001-02-02	Uso della metansolfonammide di (r)-ibuprofene e dei suoi sali non tossici per la preparazione di medicamenti per il trattamento e la prevenz
PCT/EP2002/000946 WO2002062330A2 (en)	2001-02-02	2002-01-30	Use of (r)-ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs

Publications (2)

Publication Number	Publication Date
PL363576A1 true PL363576A1 (pl)	2004-11-29
PL215109B1 PL215109B1 (pl)	2013-10-31

Family

ID=11446717

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL363576A PL215109B1 (pl)	2001-02-02	2002-01-30	Zastosowanie (R)-ibuprofeno-metanosulfonamidu i jego nietoksycznych soli do wytwarzania leków

Country Status (26)

Country	Link
US (1)	US7560487B2 (pl)
EP (1)	EP1355641B1 (pl)
JP (1)	JP2004517948A (pl)
KR (1)	KR100857898B1 (pl)
CN (1)	CN1561205A (pl)
AT (1)	ATE304846T1 (pl)
AU (1)	AU2002250869B2 (pl)
BR (2)	BR0206804A (pl)
CA (1)	CA2432432C (pl)
CZ (1)	CZ303665B6 (pl)
DE (1)	DE60206245T2 (pl)
DK (1)	DK1355641T3 (pl)
EE (1)	EE05233B1 (pl)
ES (1)	ES2248541T3 (pl)
HU (1)	HU229070B1 (pl)
IL (1)	IL157180A (pl)
IT (1)	ITMI20010206A1 (pl)
MX (1)	MXPA03006686A (pl)
NO (1)	NO334285B1 (pl)
NZ (1)	NZ526655A (pl)
PL (1)	PL215109B1 (pl)
PT (1)	PT1355641E (pl)
RU (1)	RU2257895C2 (pl)
SK (1)	SK287632B6 (pl)
WO (1)	WO2002062330A2 (pl)
ZA (1)	ZA200304861B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1579859T3 (da) *	2004-03-25	2007-04-10	Dompe Pha R Ma Spa Res & Mfg	Anvendelse af N-(2-arylpropionyl)-sulfonamider til behandling af rygmarvsskader
CA2607953A1 (en)	2005-05-09	2006-11-16	Tap Pharmaceutical Products, Inc.	Methods for treating nephrolithiasis
EP2101761A4 (en) *	2006-11-13	2010-01-27	Takeda Pharmaceuticals North A	METHODS FOR PRESERVING RENAL FUNCTION USING XANTHINE OXYDOREDUCTASE INHIBITORS
EP2308484A1 (en) *	2009-10-06	2011-04-13	Dompé S.p.a.	Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets
EP2308485A1 (en)	2009-10-06	2011-04-13	Dompé S.p.a.	Sulfonamides for the prevention of diabetes
AU2011299153B2 (en)	2010-09-10	2014-10-30	Takeda Pharmaceuticals U.S.A., Inc.	Methods for concomitant treatment of theophylline and febuxostat
US10046002B2 (en)	2013-08-02	2018-08-14	Syntrix Biosystems Inc.	Method for treating cancer using chemokine antagonists
US10561676B2 (en) *	2013-08-02	2020-02-18	Syntrix Biosystems Inc.	Method for treating cancer using dual antagonists of CXCR1 and CXCR2
CA3055004C (en) *	2017-03-15	2023-10-03	Numares Ag	Use of a marker set for determining the risk of kidney rejection

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4879283A (en) *	1985-10-03	1989-11-07	Wisconsin Alumni Research Foundation	Solution for the preservation of organs
RU2008901C1 (ru) *	1991-03-29	1994-03-15	Донецкий государственный медицинский институт им.М.Горького	Способ фармакологической защиты децентрализованной почки
ATE257389T1 (de) *	1992-09-17	2004-01-15	Amgen Inc	Pharmazeutische zusammensetzungen mit interleukin-1 inhibitoren
IL110296A (en) *	1993-07-16	1999-12-31	Smithkline Beecham Corp	Imidazole compounds process for their preparation and pharmaceutical compositions containing them
JPH08231413A (ja) *	1994-12-29	1996-09-10	Mochida Pharmaceut Co Ltd	臓器障害に基づく疾患の予防・治療剤
IT1303249B1 (it) *	1998-10-23	2000-11-06	Dompe Spa	Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
US6355682B1 (en) *	2001-05-11	2002-03-12	Assa Weinberg	Treatment of acute renal failure by administration of N-acetylcysteine

2001
- 2001-02-02 IT IT2001MI000206A patent/ITMI20010206A1/it unknown
2002
- 2002-01-30 BR BR0206804-4A patent/BR0206804A/pt not_active IP Right Cessation
- 2002-01-30 PT PT02719742T patent/PT1355641E/pt unknown
- 2002-01-30 EP EP02719742A patent/EP1355641B1/en not_active Expired - Lifetime
- 2002-01-30 HU HU0303024A patent/HU229070B1/hu not_active IP Right Cessation
- 2002-01-30 KR KR1020037009714A patent/KR100857898B1/ko not_active Expired - Fee Related
- 2002-01-30 EE EEP200300340A patent/EE05233B1/xx not_active IP Right Cessation
- 2002-01-30 SK SK973-2003A patent/SK287632B6/sk not_active IP Right Cessation
- 2002-01-30 DK DK02719742T patent/DK1355641T3/da active
- 2002-01-30 AU AU2002250869A patent/AU2002250869B2/en not_active Ceased
- 2002-01-30 JP JP2002562337A patent/JP2004517948A/ja active Pending
- 2002-01-30 NZ NZ526655A patent/NZ526655A/en not_active IP Right Cessation
- 2002-01-30 RU RU2003126600/15A patent/RU2257895C2/ru not_active IP Right Cessation
- 2002-01-30 CA CA002432432A patent/CA2432432C/en not_active Expired - Fee Related
- 2002-01-30 AT AT02719742T patent/ATE304846T1/de active
- 2002-01-30 CN CNA028042263A patent/CN1561205A/zh active Pending
- 2002-01-30 BR BRPI0206804A patent/BRPI0206804B1/pt unknown
- 2002-01-30 PL PL363576A patent/PL215109B1/pl unknown
- 2002-01-30 CZ CZ20032095A patent/CZ303665B6/cs not_active IP Right Cessation
- 2002-01-30 ES ES02719742T patent/ES2248541T3/es not_active Expired - Lifetime
- 2002-01-30 DE DE60206245T patent/DE60206245T2/de not_active Expired - Lifetime
- 2002-01-30 WO PCT/EP2002/000946 patent/WO2002062330A2/en not_active Ceased
- 2002-01-30 MX MXPA03006686A patent/MXPA03006686A/es active IP Right Grant
2003
- 2003-01-30 US US10/250,465 patent/US7560487B2/en not_active Expired - Fee Related
- 2003-06-23 ZA ZA200304861A patent/ZA200304861B/en unknown
- 2003-07-18 NO NO20033273A patent/NO334285B1/no not_active IP Right Cessation
- 2003-07-31 IL IL157180A patent/IL157180A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP1355641B1 (en)	2005-09-21
ES2248541T3 (es)	2006-03-16
WO2002062330A2 (en)	2002-08-15
MXPA03006686A (es)	2004-05-31
EE200300340A (et)	2003-10-15
US7560487B2 (en)	2009-07-14
ATE304846T1 (de)	2005-10-15
PT1355641E (pt)	2005-11-30
DE60206245D1 (de)	2006-02-02
KR20030074725A (ko)	2003-09-19
RU2003126600A (ru)	2005-02-27
EE05233B1 (et)	2009-12-15
IL157180A (en)	2009-06-15
HU229070B1 (hu)	2013-07-29
AU2002250869B2 (en)	2006-10-19
CZ303665B6 (cs)	2013-02-20
RU2257895C2 (ru)	2005-08-10
HUP0303024A3 (en)	2005-07-28
ZA200304861B (en)	2004-06-30
CA2432432C (en)	2008-03-25
NO20033273D0 (no)	2003-07-18
US20040102520A1 (en)	2004-05-27
DK1355641T3 (da)	2005-10-17
NO20033273L (no)	2003-07-18
ITMI20010206A1 (it)	2002-08-02
CN1561205A (zh)	2005-01-05
BR0206804A (pt)	2004-02-03
JP2004517948A (ja)	2004-06-17
CZ20032095A3 (en)	2004-05-12
SK9732003A3 (en)	2003-11-04
SK287632B6 (sk)	2011-04-05
NZ526655A (en)	2005-02-25
BRPI0206804B1 (pt)	2018-09-25
DE60206245T2 (de)	2006-06-14
NO334285B1 (no)	2014-01-27
PL215109B1 (pl)	2013-10-31
KR100857898B1 (ko)	2008-09-10
HUP0303024A2 (hu)	2003-12-29
WO2002062330A3 (en)	2003-04-03
EP1355641A2 (en)	2003-10-29
CA2432432A1 (en)	2002-08-15

Publication	Publication Date	Title
ATE517624T1 (de)	2011-08-15	Behandlung von neurodegenerativen erkrankungen und krebs im gehirn
ATE248837T1 (de)	2003-09-15	Chinuclidin-acrylamide
EP0509317A3 (en)	1993-03-03	Use of droloxifene in the treatment of bone diseases
DE50311898D1 (de)	2009-10-22	Fredericamycin-derivate als arzneimittel zur tumorbehandlung
DE60118604D1 (de)	2006-05-18	Photosensibilisator-enthaltende lagerungslösung zur inaktivierung von biologischen verunreinigungen
MXPA04004601A (es)	2004-08-13	Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.
PT1091747E (pt)	2004-06-30	Utilizacao de solucoes salinas isotermicas para a prevencao de inflamacoes
EP1350511A4 (en)	2004-06-23	MEDICAL COMPOSITIONS CONTAINING ASPIRIN
ATE496048T1 (de)	2011-02-15	Phenylcarboxamidverbindungen zur schmerzbehandlung
EP1197210A4 (en)	2005-02-16	MEANS TO PREVENT THE CHRONIC BREATHING REACTION AS A RESULT OF AN ORGANTRANSPLANTATION
PL363576A1 (pl)	2004-11-29	Zastosowanie (R)-ibuprofeno-metanosulfonamidu i jego soli do leczenia i zapobiegania reakcjom odrzucania przeszczepionych organów
DK1001792T3 (da)	2004-01-19	Anvendelse af fysiologisk acceptable vanadiumforbindelser, -salte og -komplekser
MXPA04003506A (es)	2004-07-23	Metodo para la preparacion de una composicion farmaceutica que comprende acido 5-aminosalicilico para el uso en el tratamiento de la colitis ulcerativa y de la enfermedad de crohn.
WO2003024941A1 (en)	2003-03-27	Naphthalene compounds and use thereof as drugs
ATE344662T1 (de)	2006-11-15	Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
DE602004022783D1 (de)	2009-10-08	Heterozyklische harnstoff-derivate für die behandlung von schmerzen.
PT1091746E (pt)	2002-07-31	Utilizacao de solucoes salinas isoosmoticas para a preparacao de medicamentos cerumenoliticos
ATE521344T1 (de)	2011-09-15	Calciumsalze zur behandlung von psoriasis, dermatitis und schuppen
IL170519A (en)	2010-12-30	Use of fenofibrate or pharmaceutically acceptable salt thereof, orlistat and pharmaceutically acceptable carrier in the manufacture of medicaments for the treatment of obesity and pharmaceutical compositions containing them
WO2003039231A3 (en)	2003-10-16	Compounds and methods for treating transplant rejection
ATE487462T1 (de)	2010-11-15	Zubereitung zur vorbeugung und behandlung von akne enthaltend zinkgluconat und kupfergluconat
PL1514545T3 (pl)	2008-07-31	Zastosowanie tolperyzonu do leczenia skurczów narządów zbudowanych zasadniczo z mięśni gładkich
TH67520A (th)	2005-02-21	การรักษาหน้าที่เนื้อเยื่อปลูกถ่ายที่ช้า
ATE464042T1 (de)	2010-04-15	Verwendung von neboglamine zur behandlung von schizophrenie
RU2000115437A (ru)	2002-06-20	Способ лечения бронхиальной астмы